Quanterix Corporation (QTRX)

Market Cap	423.38M
Revenue (ttm)	133.81M
Net Income (ttm)	-35.72M
Shares Out	38.52M
EPS (ttm)	-0.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	91,764
Open	10.95
Previous Close	11.06
Day's Range	10.72 - 11.03
52-Week Range	9.87 - 29.70
Beta	1.31
Analysts	Strong Buy
Price Target	23.25 (+111.56%)
Earnings Date	Feb 24, 2025

About QTRX

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 7, 2017
• Employees: 441
• Stock Exchange: NASDAQ
• Ticker Symbol: QTRX
• Website: https://www.quanterix.com

Financial Performance

In 2023, Quanterix's revenue was $122.37 million, an increase of 15.96% compared to the previous year's $105.52 million. Losses were -$28.35 million, -71.52% less than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for QTRX stock is "Strong Buy." The 12-month stock price forecast is $23.25, which is an increase of 111.56% from the latest price.

Price Target

$23.25

(111.56% upside)

Analyst Consensus: Strong Buy